118 related articles for article (PubMed ID: 21537160)
1. Patients with deep venous thrombosis and thrombophilia risk factors have a specific prolongation of the lag time in a chromogenic thrombin generation assay.
Haas FJ; Kluft C; Biesma DH; Schutgens RE
Blood Coagul Fibrinolysis; 2011 Sep; 22(6):506-11. PubMed ID: 21537160
[TBL] [Abstract][Full Text] [Related]
2. Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry.
Linnemann B; Meister F; Schwonberg J; Schindewolf M; Zgouras D; Lindhoff-Last E;
Thromb Haemost; 2008 Sep; 100(3):440-6. PubMed ID: 18766260
[TBL] [Abstract][Full Text] [Related]
3. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
4. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities.
Martinelli I; Battaglioli T; Bucciarelli P; Passamonti SM; Mannucci PM
Circulation; 2004 Aug; 110(5):566-70. PubMed ID: 15262837
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for thrombophilia in extrahepatic portal vein obstruction.
Primignani M; Martinelli I; Bucciarelli P; Battaglioli T; Reati R; Fabris F; Dell'era A; Pappalardo E; Mannucci PM
Hepatology; 2005 Mar; 41(3):603-8. PubMed ID: 15726653
[TBL] [Abstract][Full Text] [Related]
6. Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test.
Curvers J; Thomassen MC; Rimmer J; Hamulyak K; van der Meer J; Tans G; Preston FE; Rosing J
Thromb Haemost; 2002 Jul; 88(1):5-11. PubMed ID: 12152677
[TBL] [Abstract][Full Text] [Related]
7. Contribution of multiple thrombophilic and transient risk factors in the development of cerebral venous thrombosis.
Libourel EJ; ten Kate MK; Brouwer JL; Veeger NJ; van der Meer J
Thromb Res; 2007; 121(3):301-7. PubMed ID: 17543373
[TBL] [Abstract][Full Text] [Related]
8. D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study.
Andreescu AC; Cushman M; Rosendaal FR
Thromb Haemost; 2002 Jan; 87(1):47-51. PubMed ID: 11858188
[TBL] [Abstract][Full Text] [Related]
9. Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state.
Dahm A; Rosendaal FR; Andersen TO; Sandset PM
Br J Haematol; 2006 Feb; 132(3):333-8. PubMed ID: 16409298
[TBL] [Abstract][Full Text] [Related]
10. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
11. Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence.
van Hylckama Vlieg A; Christiansen SC; Luddington R; Cannegieter SC; Rosendaal FR; Baglin TP
Br J Haematol; 2007 Sep; 138(6):769-74. PubMed ID: 17760809
[TBL] [Abstract][Full Text] [Related]
12. The risk of symptomatic pulmonary embolism due to proximal deep venous thrombosis differs in patients with different types of inherited thrombophilia.
Rossi E; Za T; Ciminello A; Leone G; De Stefano V
Thromb Haemost; 2008 Jun; 99(6):1030-4. PubMed ID: 18521504
[TBL] [Abstract][Full Text] [Related]
13. Enhanced thrombin generation in women with a history of oral contraception-related venous thrombosis.
Anžej Doma S; Vučnik M; Božič Mijovski M; Peternel P; Stegnar M
Thromb Res; 2013 Nov; 132(5):621-6. PubMed ID: 24083963
[TBL] [Abstract][Full Text] [Related]
14. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis.
Wysokinska EM; Wysokinski WE; Brown RD; Karnicki K; Gosk-Beirska I; Grill D; McBane RD
Neurology; 2008 Feb; 70(8):627-33. PubMed ID: 18285537
[TBL] [Abstract][Full Text] [Related]
15. Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism.
Goldenberg N; Kahn SR; Solymoss S
J Clin Oncol; 2003 Nov; 21(22):4194-9. PubMed ID: 14615447
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of annexin V binding to cardiolipin and thrombin generation in an unselected population with venous thrombosis.
Hanly JG; Smith SA; Anderson D
J Rheumatol; 2003 Sep; 30(9):1990-3. PubMed ID: 12966603
[TBL] [Abstract][Full Text] [Related]
17. Thrombophilic variables do not increase the generation or procoagulant activity of thrombin during cardiopulmonary bypass.
Raivio P; Petäjä J; Kuitunen A; Lassila R
Ann Thorac Surg; 2008 Feb; 85(2):536-42. PubMed ID: 18222259
[TBL] [Abstract][Full Text] [Related]
18. Thrombophilia testing in patients with venous thrombosis.
Caprini JA; Goldshteyn S; Glase CJ; Hathaway K
Eur J Vasc Endovasc Surg; 2005 Nov; 30(5):550-5. PubMed ID: 16055356
[TBL] [Abstract][Full Text] [Related]
19. A thrombin generation assay may reduce the need for compression ultrasonography for the exclusion of deep venous thrombosis in the elderly.
Haas FJ; Schutgens RE; Kluft C; Biesma DH
Scand J Clin Lab Invest; 2011 Feb; 71(1):12-8. PubMed ID: 21073394
[TBL] [Abstract][Full Text] [Related]
20. Do we need screening for thrombophilia prior to kidney transplantation?
Andrassy J; Zeier M; Andrassy K
Nephrol Dial Transplant; 2004 Jul; 19 Suppl 4():iv64-8. PubMed ID: 15240853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
